Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Top 200 Drug Matching Game

Top 200 Drug Matching Game

By Christopher Whitehead

Top 200 Drug Matching Game is an educational quiz app for pharmacy certification prep on iOS.

The App DNA

What makes this app unique?

Users hire this app to memorize drug names and prescription codes for the PTCB exam, but the current technical friction prevents the job from being completed.

For Pharmacy technicians, nursing students, and medical professionals preparing for national certification exams.

What does it look like?

Key features

Drug Matching Gamestandard

Interactive quiz mode for drug identification, gated by $5.99 purchase.

Pharmacy Sig Traineredge

Practice module for prescription codes, gated by $21.95/month membership.

PTCB Exam Modeedge

Simulated testing environment for certification prep.

How much does it cost?

freemium$5.99 upfront purchase$21.95/month membership$99.00/6-month membership$159.00/year membership

Hybrid model combining one-time purchase with recurring membership tiers for web-based library access.

Velocity

Dormant developmentperformanceShow more...

Development has effectively ceased, with no new feature builds or updates released in the last year. The latest release, which focused on performance improvements, arrived 369 days ago. Given the lack of activity across both Android and iOS platforms, the app is currently in a zombie state.

See all version history

Who built it?

Christopher Whitehead

12 apps tracked · Education

Top 20 Drugs Matching GameTop 20 Drugs Matching GameTop 200 Drug PronunciationsTop 200 Drug PronunciationsTop 200 Pharmacy Drug CardsTop 200 Pharmacy Drug CardsTop 200 Drug Touch Match GameTop 200 Drug Touch Match GameCardiovasular Drugs FlashcardsCardiovasular Drugs FlashcardsCardiovascular Drugs Matching Cardiovascular Drugs Matching 200 Drug Matching Game200 Drug Matching GamePharmacy Flashcards DemoPharmacy Flashcards DemoTop 200 Drug NamesTop 200 Drug Names200 Pharmacy Drugs Flashcards200 Pharmacy Drugs Flashcards200 Drug Touch Matching Demo200 Drug Touch Matching Demo
Explore the full publisher profile

User Sentiment

What do users think recently?

Review voice lately leans upset.

How are ratings & reviews evolving?

App Store
2.50 · 10

What users say, by theme

What Frustrates Users
  • Technical failure prevents the game from launching even after following the screen rotation instructions
+ 1 more theme

3 of 3 recent reviews analyzed · limited sample

Read the full review analysis

Unlock 1 more frustration theme, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for Top 200 Drug Matching Game

How's the Education market?

The app occupies a narrow educational niche, but its #96 Paid rank in the US category is threatened by a 2.5-star rating and a 369-day update drought. The lack of recent maintenance signals a high risk of abandonment relative to active competitors.

Read the market outlook

The rivals identified

PTCB Exam Prep 2026 | EZPrep

By EZ Test Prep

This app directly targets the same Pharmacy Technician Certification Exam audience with a dedicated, high-frequency study platform.

  • Provides comprehensive exam-style practice questions rather than simple drug-matching flashcards.
  • Maintains a consistent release cadence to keep study content aligned with current exam standards.
  • Offers a structured learning path that guides users through the entire certification curriculum.
Top 200 Drug Matching Game vs PTCB Exam Prep 2026 | EZPrep

Unlock the head-to-head verdict: where this rival wins, and where it loses.

Access the full report for free

The Analyst's Read

Key takeaways for Top 200 Drug Matching Game

Where is it heading?

The pharmacy certification market is consolidating around high-frequency, subscription-based prep platforms that offer detailed rationales and analytics. This app's reliance on a static, one-time purchase model and its failure to resolve basic launch bugs leave it exposed to total market share erosion.

  • The 369-day update drought suggests the product is in maintenance mode, which prevents it from keeping pace with evolving PTCB exam standards.
  • Persistent launch failures on the latest build prevent users from accessing the paid content, leading to a 2.5-star rating and high churn.

The SWOT

Core Strengths
  • PTCB Advocate Educator program status validates exam alignment
Critical Frictions 2 weaknesses inside
Growth Levers
  • Implement free-to-try model to compete with Quizlet
Market Threats 1 threat identified

Next best moves

1 Invest · 1 Pivot

Audit launch sequence because users report persistent crashes on startup → restore core functionality

+ 1 more prioritized move

The counter-intuitive read

The app's biggest risk is not the competition, but its own maintenance-mode status…

Read the full take

Feature gaps

Detailed answer rationales (available in EZPrep but missing here) +1

Bottom line

The app provides a niche utility for pharmacology memorization, but technical instability and an outdated pricing model drive user churn. The PM must prioritize fixing launch regressions before attempting to scale the membership-gated study modules.

Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.

Access the full report for free

Sources

  1. [1] App Store, source

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Top 200 Drug Matching Game, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “Top 200 Drug Matching Game Intelligence Report.” Updated Jul 27, 2026. https://marlvel.ai/apps/com-denalirx-app-pyramid-ios

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0